Ouyang S, Lu P, Li J, Jin H, Wu W, Luo R
Respir Res. 2024; 25(1):311.
PMID: 39154188
PMC: 11330596.
DOI: 10.1186/s12931-024-02947-3.
Li Z, Yang Y, Gao F
Inflammopharmacology. 2024; 32(4):2203-2217.
PMID: 38724690
DOI: 10.1007/s10787-024-01485-0.
Chen L, Deng Y, Wang T, Lin X, Zheng L, Chen X
BMC Pulm Med. 2023; 23(1):461.
PMID: 37993830
PMC: 10664472.
DOI: 10.1186/s12890-023-02762-4.
Prades-Sagarra E, Yaromina A, Dubois L
Cancers (Basel). 2023; 15(9).
PMID: 37173877
PMC: 10177176.
DOI: 10.3390/cancers15092412.
Adamcakova J, Balentova S, Barosova R, Hanusrichterova J, Mikolka P, Prso K
Int J Mol Sci. 2023; 24(3).
PMID: 36768179
PMC: 9916388.
DOI: 10.3390/ijms24031857.
Therapeutic Effects of Green Tea Polyphenol (‒)-Epigallocatechin-3-Gallate (EGCG) in Relation to Molecular Pathways Controlling Inflammation, Oxidative Stress, and Apoptosis.
Mokra D, Joskova M, Mokry J
Int J Mol Sci. 2023; 24(1).
PMID: 36613784
PMC: 9820274.
DOI: 10.3390/ijms24010340.
Challenges in the Management of Post-COVID-19 Pulmonary Fibrosis for the Latin American Population.
Cherrez-Ojeda I, Cortes-Telles A, Gochicoa-Rangel L, Camacho-Leon G, Mautong H, Robles-Velasco K
J Pers Med. 2022; 12(9).
PMID: 36143178
PMC: 9501763.
DOI: 10.3390/jpm12091393.
Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG): A Time for a New Player in the Treatment of Respiratory Diseases?.
Mokra D, Adamcakova J, Mokry J
Antioxidants (Basel). 2022; 11(8).
PMID: 36009285
PMC: 9405266.
DOI: 10.3390/antiox11081566.
Promising natural products against SARS-CoV-2: Structure, function, and clinical trials.
Zhao Y, Deng S, Bai Y, Guo J, Kai G, Huang X
Phytother Res. 2022; 36(10):3833-3858.
PMID: 35932157
PMC: 9538226.
DOI: 10.1002/ptr.7580.
Epigallocatechin-3-gallate attenuates myocardial fibrosis in diabetic rats by activating autophagy.
Jia Q, Yang R, Mehmood S, Li Y
Exp Biol Med (Maywood). 2022; 247(17):1591-1600.
PMID: 35833541
PMC: 9554167.
DOI: 10.1177/15353702221110646.
Fibropreventive and Antifibrotic Effects of Uncaria gambir on Rats with Pulmonary Fibrosis.
Desdiani D, Rengganis I, Djauzi S, Setiyono A, Sadikin M, Jusman S
Evid Based Complement Alternat Med. 2022; 2022:6721958.
PMID: 35795272
PMC: 9251096.
DOI: 10.1155/2022/6721958.
Potential Application of Tea Polyphenols to the Prevention of COVID-19 Infection: Based on the Gut-Lung Axis.
Xu L, Ho C, Liu Y, Wu Z, Zhang X
Front Nutr. 2022; 9:899842.
PMID: 35495940
PMC: 9046984.
DOI: 10.3389/fnut.2022.899842.
The Effect of Ophiopogonin C in Ameliorating Radiation-Induced Pulmonary Fibrosis in C57BL/6 Mice: An Update Study.
Fu X, Li T, Yao Q
Front Oncol. 2022; 12:811183.
PMID: 35433490
PMC: 9007236.
DOI: 10.3389/fonc.2022.811183.
Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis.
Estornut C, Milara J, Bayarri M, Belhadj N, Cortijo J
Front Pharmacol. 2022; 12:794997.
PMID: 35126133
PMC: 8815729.
DOI: 10.3389/fphar.2021.794997.
Therapeutic Effects and Molecular Mechanisms of Bioactive Compounds Against Respiratory Diseases: Traditional Chinese Medicine Theory and High-Frequency Use.
Wang J, Wu Q, Ding L, Song S, Li Y, Shi L
Front Pharmacol. 2021; 12:734450.
PMID: 34512360
PMC: 8429615.
DOI: 10.3389/fphar.2021.734450.
Evaluation of Epigallocatechin-3-Gallate as a Radioprotective Agent During Radiotherapy of Lung Cancer Patients: A 5-Year Survival Analysis of a Phase 2 Study.
Zhu W, Zhao Y, Zhang S, Li X, Xing L, Zhao H
Front Oncol. 2021; 11:686950.
PMID: 34178681
PMC: 8223749.
DOI: 10.3389/fonc.2021.686950.
Potential protective mechanisms of green tea polyphenol EGCG against COVID-19.
Zhang Z, Zhang X, Bi K, He Y, Yan W, Yang C
Trends Food Sci Technol. 2021; 114:11-24.
PMID: 34054222
PMC: 8146271.
DOI: 10.1016/j.tifs.2021.05.023.
The Effects of Epigallocatechin Gallate (EGCG) on Pulmonary Fibroblasts of Idiopathic Pulmonary Fibrosis (IPF)-A Next-Generation Sequencing and Bioinformatic Approach.
Tsai M, Chang W, Liao S, Chang K, Sheu C, Kuo P
Int J Mol Sci. 2019; 20(8).
PMID: 31013581
PMC: 6514693.
DOI: 10.3390/ijms20081958.
Cytokines and radiation-induced pulmonary injuries.
Lierova A, Jelicova M, Nemcova M, Proksova M, Pejchal J, Zarybnicka L
J Radiat Res. 2018; 59(6):709-753.
PMID: 30169853
PMC: 6251431.
DOI: 10.1093/jrr/rry067.
Tanshinone II is a potent candidate for treatment of lipopolysaccharide-induced acute lung injury in rat model.
Li L, Zhang Y, Tan Y, Zhao J, Zhang H, Zhao B
Oncol Lett. 2018; 15(2):2550-2554.
PMID: 29434972
PMC: 5777273.
DOI: 10.3892/ol.2017.7581.